Author(s): Bunzow JR, Sonders MS, Arttamangkul S, Harrison LM, Zhang G, et al.
The trace amine para-tyramine is structurally and functionally related to the amphetamines and the biogenic amine neurotransmitters. It is currently thought that the biological activities elicited by trace amines such as p-tyramine and the psychostimulant amphetamines are manifestations of their ability to inhibit the clearance of extracellular transmitter and/or stimulate the efflux of transmitter from intracellular stores. Here we report the discovery and pharmacological characterization of a rat G protein-coupled receptor that stimulates the production of cAMP when exposed to the trace amines p-tyramine, beta-phenethylamine, tryptamine, and octopamine. An extensive pharmacological survey revealed that psychostimulant and hallucinogenic amphetamines, numerous ergoline derivatives, adrenergic ligands, and 3-methylated metabolites of the catecholamine neurotransmitters are also good agonists at the rat trace amine receptor 1 (rTAR1). These results suggest that the trace amines and catecholamine metabolites may serve as the endogenous ligands of a novel intercellular signaling system found widely throughout the vertebrate brain and periphery. Furthermore, the discovery that amphetamines, including 3,4-methylenedioxymethamphetamine (MDMA; "ecstasy"), are potent rTAR1 agonists suggests that the effects of these widely used drugs may be mediated in part by this receptor as well as their previously characterized targets, the neurotransmitter transporter proteins.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/11723224
Author(s): Hökfelt T, Ljungdahl A, Fuxe K, Johansson O
Author(s): Toru M, Nishikawa T, Mataga N, Takashima M
Author(s): Watis L, Chen SH, Chua HC, Chong SA, Sim K
Author(s): Olbrich HM, Valerius G, Rüsch N, Buchert M, Thiel T, et al.
Author(s): Christison GW, Casanova MF, Weinberger DR, Rawlings R, Kleinman JE
Author(s): McGlashan TH, Hoffman RE
Author(s): Duan X, Chang JH, Ge S, Faulkner RL, Kim JY, et al.
Author(s): Reif A, Fritzen S, Finger M, Strobel A, Lauer M, et al.
Author(s): Ikemoto K, Nishimura A, Oda T, Nagatsu I, Nishi K
Author(s): Jaeger CB, Teitelman G, Joh TH, Albert VR, Park DH, et al.
Author(s): Boulton AA, Juorio AV
Author(s): Jaeger CB, Ruggiero DA, Albert VR, Park DH, Joh TH, et al.
Author(s): Tashiro Y, Kaneko T, Sugimoto T, Nagatsu I, Kikuchi H, et al.
Author(s): Mura A, Linder JC, Young SJ, Groves PM
Author(s): Ikemoto K, Kitahama K, Jouvet A, Arai R, Nishimura A, et al.
Author(s): Ikemoto K, Nagatsu I, Kitahama K, Jouvet A, Nishimura A, et al.
Author(s): Kitahama K, Ikemoto K, Jouvet A, Nagatsu I, Sakamoto N, et al.
Author(s): Kitahama K, Ikemoto K, Jouvet A, Araneda S, Nagatsu I, et al.
Author(s): Ikemoto K
Author(s): Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, et al.
Author(s): Miller GM
Author(s): Xie Z, Miller GM
Author(s): Xie Z, Miller GM
Author(s): Lindemann L, Meyer CA, Jeanneau K, Bradaia A, Ozmen L, et al.
Author(s): Zucchi R, Chiellini G, Scanlan TS, Grandy DK
Author(s): Bradaia A, Trube G, Stalder H, Norcross RD, Ozmen L, et al.